DOCTORS HOSPITAL
1. Target Overview & Investment Thesis
DOCTORS HOSPITAL is a 9-bed safety-net/medicaid heavy in JOHNSON, KS with $14.7M in net patient revenue and a -19.2% operating margin. The hospital serves a payer mix of 29.1% Medicare, 34.7% Medicaid, and 36.2% commercial.
Thesis: Turnaround. Our ML models identify $1.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -19.2% to -11.8% (+736bps).
| Net Revenue HCRIS | $14.7M |
| Current EBITDA COMPUTED | $-2.8M |
| Operating Margin COMPUTED | -19.2% |
| Occupancy HCRIS | 19.6% |
| Revenue / Bed COMPUTED | $1.6M |
| Net-to-Gross HCRIS | 15.8% |
| Distress Probability ML | 60.2% |
2. Market Context & Competitive Position
KS has 152 Medicare-certified hospitals with a median operating margin of -17.7%. The target's margin of -19.2% places it below the state median. Among 35 size-comparable peers (4-18 beds), the median margin is -18.7%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (4-18), prioritizing same-state peers. 35 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| DOCTORS HOSPITAL (Target) | KS | 9 | $14.7M | -19.2% |
| KANSAS CITY ORTHOPAEDIC INSTIT | KS | 17 | $86.3M | 21.1% |
| MANHATTAN SURGICAL HOSPITAL | KS | 13 | $42.0M | 13.1% |
| CLARA BARTON HOSPITAL ASSOCIAT | KS | 18 | $35.1M | -8.2% |
| SALINA SURGICAL HOSPITAL | KS | 16 | $28.3M | 20.9% |
| MIAMI COUNTY MEDICAL CENTER | KS | 18 | $28.0M | -17.2% |
| ANDERSON COUNTY HOSPITAL | KS | 12 | $27.8M | -15.4% |
| MITCHELL CO HOSP HEALTH SYSTEM | KS | 18 | $27.4M | -7.4% |
| HOLTON COMMUNITY HOSPITAL | KS | 14 | $22.6M | -18.1% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.1M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $309K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $294K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $291K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $179K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +7bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-2.8M |
| + RCM Uplift | +$1.1M |
| Pro Forma EBITDA | $-1.7M |
| Current Margin | -19.2% |
| Pro Forma Margin | -11.8% |
| WC Released (1x) | $563K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-4.3M | $-7.8M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-4.3M | $-9.9M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-3.9M | $-7.8M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-3.9M | $-9.6M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-4.8M | $-11.8M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-4.8M | $-14.5M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Elevated Medicaid exposure (34.7%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| Medium | Low occupancy | At 19.6%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 60.2% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 35 hospitals with 4-18 beds
- Same-state prioritization (n=38)
- Comp margins: P25=-35.9% / P50=-18.7% / P75=-7.8%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.